Boothbay Fund Management, LLC Rain Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.77 - $12.47 $4,467 - $7,170	-575 Reduced 4.37%	12,582 $109,000
Q4 2022 Feb 14, 2023	BUY	$5.52 - $8.48 $72,626 - $111,571	13,157 New	13,157 $105,000
Q4 2021 Feb 14, 2022	SELL	$11.91 - $17.0 $184,902 - $263,925	-15,525 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.21 - $20.91 $205,085 - $324,627	15,525 New	15,525 $232,000

122K

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.